{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:11:48Z","timestamp":1793052708058,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","award":["RGP-1438-005"],"award-info":[{"award-number":["RGP-1438-005"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.07.126","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T14:44:00Z","timestamp":1533825840000},"page":"347-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Sitagliptin attenuates myocardial apoptosis via activating LKB-1\/AMPK\/Akt pathway and suppressing the activity of GSK-3\u03b2 and p38\u03b1\/MAPK in a rat model of diabetic cardiomyopathy"],"prefix":"10.1016","volume":"107","author":[{"given":"Nouf T.","family":"Al-Damry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-5363","authenticated-orcid":false,"given":"Hala A.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal M.","family":"Al-Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf M.","family":"Al-Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raeesa A.","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-0840","authenticated-orcid":false,"given":"Maha A.","family":"Al-Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3395-5754","authenticated-orcid":false,"given":"Nduna","family":"Dizmiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Atteya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.07.126_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.biopha.2018.07.126_bib0010","doi-asserted-by":"crossref","first-page":"H1489","DOI":"10.1152\/ajpheart.00278.2006","article-title":"Role of changes in cardiac metabolism in development of diabetic cardiomyopathy","volume":"291","author":"An","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1055\/s-2007-985823","article-title":"Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy?","volume":"39","author":"Kuethe","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.RES.0000148632.35500.d9","article-title":"The mitochondrial death pathway and cardiac myocyte apoptosis","volume":"95","author":"Crow","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10863-009-9205-y","article-title":"Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue","volume":"41","author":"Miyamoto","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.biopha.2018.07.126_bib0040","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3892\/mmr.2015.4724","article-title":"Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K\/Akt\/Bad signaling pathway","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1530\/JME-15-0155","article-title":"GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt\/GSK3b\/b-catenin pathway","volume":"55","author":"Ying","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0050","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1152\/japplphysiol.00853.2003","article-title":"Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats","volume":"96","author":"Lajoie","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/aps.2010.52","article-title":"Ginsenoside Rb1 protects cardiomyocytes against CoCl2-induced apoptosis in neonatal rats by inhibiting mitochondria permeability transition pore opening","volume":"31","author":"Kong","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.07.126_bib0060","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/db08-1697","article-title":"Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling","volume":"58","author":"Wang","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0065","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db09-0158","article-title":"Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition","volume":"58","author":"Miki","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0070","doi-asserted-by":"crossref","first-page":"74791","DOI":"10.18632\/oncotarget.20422","article-title":"Diallyl trisulfide exerts cardioprotection against myocardial ischemia-reperfusion injury in diabetic state, role of AMPK-mediated AKT\/GSK-3\u03b2\/HIF-1\u03b1 activation","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.07.126_bib0075","doi-asserted-by":"crossref","first-page":"41491","DOI":"10.1038\/srep41491","article-title":"Protective effect of butin against ischemia\/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK\/GSK-3\u03b2\/Nrf2 signaling pathway","volume":"7","author":"Duan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0080","doi-asserted-by":"crossref","first-page":"41337","DOI":"10.1038\/srep41337","article-title":"Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1alpha-SIRT3 signaling","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2016.11.091","article-title":"Surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy","volume":"482","author":"Lin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.07.126_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.09.022","article-title":"Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1\/AMPK pathway","volume":"77","author":"Zhang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12967-016-0849-1","article-title":"Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy","volume":"14","author":"Zhang","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2018.07.126_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj3450437","article-title":"The regulation of AMP-activated protein kinase by phosphorylation","volume":"345","author":"Stein","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.07.126_bib0105","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0110","article-title":"The role of p38 MAPK in the development of diabetic cardiomyopathy","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.07.126_bib0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxlet.2016.06.020","article-title":"Zinc deficiency exacerbates while zinc supplement attenuates cardiac hypertrophy in high-fat diet-induced obese mice through modulating p38 MAPK-dependent signaling","volume":"258","author":"Wang","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2018.07.126_bib0120","doi-asserted-by":"crossref","first-page":"9174190","DOI":"10.1155\/2016\/9174190","article-title":"Pioglitazone protected against cardiac hypertrophy via inhibiting AKT\/GSK3B and MAPK signaling pathways","volume":"2016","author":"Wei","year":"2016","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/mmr.2016.5319","article-title":"Activation of amp-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus b3","volume":"14","author":"Jiang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0130","doi-asserted-by":"crossref","first-page":"e0119214","DOI":"10.1371\/journal.pone.0119214","article-title":"Schisandrin b prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK\/p53 signaling","volume":"10","author":"Thandavarayan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.07.126_bib0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2014.06.023","article-title":"P38- mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate","volume":"450","author":"Oh","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.07.126_bib0140","doi-asserted-by":"crossref","first-page":"8214541","DOI":"10.1155\/2017\/8214541","article-title":"Roles and mechanisms of herbal medicine for diabetic cardiomyopathy: current status and perspective","volume":"2017","author":"Tian","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2018.07.126_bib0145","doi-asserted-by":"crossref","first-page":"H911","DOI":"10.1152\/ajpheart.00124.2009","article-title":"Dominant-negative p38- mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus","volume":"297","author":"Thandavarayan","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.07.126_bib0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/CIRCHEARTFAILURE.110.952556","article-title":"Metformin use and mortality in ambulatory patients with diabetes and heart failure","volume":"4","author":"Aguilar","year":"2011","journal-title":"Circ. Heart Fail."},{"issue":"10","key":"10.1016\/j.biopha.2018.07.126_bib0155","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/diacare.28.10.2345","article-title":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure","volume":"28","author":"Eurich","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2018.07.126_bib0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.biopha.2018.07.126_bib0165","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCRESAHA.114.301958","article-title":"Cardiovascular actions of incretin-based therapies","volume":"114","author":"Ussher","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"Sauve","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2840-12-53","article-title":"Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)","volume":"12","author":"Leibovitz","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCIMAGING.113.000785","article-title":"Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients with type 2 diabetes mellitus and coronary artery disease","volume":"7","author":"McCormick","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.biopha.2018.07.126_bib0185","doi-asserted-by":"crossref","first-page":"e67009","DOI":"10.1371\/journal.pone.0067009","article-title":"Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.07.126_bib0190","first-page":"499","article-title":"The combination of zinc and glibenclamide limits cardiovascular complications in diabetic rats via multiple mechanisms","volume":"28","author":"Attia","year":"2015","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2018.07.126_bib0195","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.pharep.2015.01.010","article-title":"Immunohistochemical, apoptotic and biochemical changes by dipeptidyl peptidase-4 inhibitor-sitagliptin in type-2 diabetic rats","volume":"67","author":"Karabulut","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0200","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1463-1326.2012.01619.x","article-title":"Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic \u03b2-cell mass in a streptozotocin-induced mouse model of type 2 diabetes","volume":"14","author":"Poucher","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2018.07.126_bib0205","doi-asserted-by":"crossref","first-page":"e78330","DOI":"10.1371\/journal.pone.0078330","article-title":"Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms","volume":"8","author":"Picatoste","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.07.126_bib0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2013.12.036","article-title":"Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice","volume":"723","author":"Hemmeryckx","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0215","doi-asserted-by":"crossref","first-page":"810469","DOI":"10.1155\/2011\/810469","article-title":"Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications","volume":"2011","author":"Davidson","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0220","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10616-013-9563-5","article-title":"Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats","volume":"66","author":"Bayramoglu","year":"2014","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biopha.2018.07.126_bib0225","doi-asserted-by":"crossref","first-page":"403291","DOI":"10.1155\/2015\/403291","article-title":"Cardioprotective activity of Pongamia pinnata in Streptozotocin-Nicotinamide induced diabetic rats","volume":"2015","author":"Badole","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2018.07.126_bib0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2840-11-73","article-title":"Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1024774303744","article-title":"Mitogen activated protein kinases in the acute diabetic myocardium","volume":"249","author":"Strniskova","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.07.126_bib0240","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/aps.2010.73","article-title":"Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1\/MuRF1 signaling pathway in vitro","volume":"31","author":"Chen","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.07.126_bib0245","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","article-title":"Ceramide is a cardiotoxin in lipotoxic cardiomyopathy","volume":"49","author":"Park","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402","article-title":"Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat","volume":"1","author":"Poornima","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.biopha.2018.07.126_bib0255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.endonu.2012.07.007","article-title":"Glucagon-like peptide 1 and cardiac cell survival","volume":"59","author":"Ravassa","year":"2012","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.biopha.2018.07.126_bib0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/BJ20070936","article-title":"Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide","volume":"410","author":"Hajduch","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.07.126_bib0270","doi-asserted-by":"crossref","first-page":"22068","DOI":"10.1038\/srep22068","article-title":"Hyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heart","volume":"6","author":"Bai","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.07.126_bib0275","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1055\/s-0034-1384584","article-title":"The GLP-1 analogue liraglutide protects cardiomyocytes from high glucose-induced apoptosis by activating the Epac-1\/Akt pathway","volume":"122","author":"Wu","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0280","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db12-0533","article-title":"Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.07.126_bib0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2015.05.034","article-title":"Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK","volume":"412","author":"Guo","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0290","doi-asserted-by":"crossref","first-page":"4219735","DOI":"10.1155\/2016\/4219735","article-title":"Exenatide activates the APPL1-AMPK-PPAR\u03b1 Axis to prevent diabetic cardiomyocyte apoptosis","volume":"2016","author":"XiaoTian","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2018.07.126_bib0295","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2015.03.026","article-title":"GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats","volume":"240","author":"Inoue","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2018.07.126_bib0300","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2017.03.029","article-title":"Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat","volume":"448","author":"Zhang","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2018.07.126_bib0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11883-013-0314-z","article-title":"Metformin therapy in diabetes: the role of cardioprotection","volume":"15","author":"El Messaoudi","year":"2013","journal-title":"Curr. Atheroscler. Rep."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218304608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218304608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:21:30Z","timestamp":1766024490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218304608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":61,"alternative-id":["S0753332218304608"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.126","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sitagliptin attenuates myocardial apoptosis via activating LKB-1\/AMPK\/Akt pathway and suppressing the activity of GSK-3\u03b2 and p38\u03b1\/MAPK in a rat model of diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.07.126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}